$CME

CME Group Reports Record Q3 Revenue of $1.74B, Adjusted Diluted EPS $3.02

CME Group reported Q3 2026 revenue of $1.74B, net income of $1.04B, and adjusted diluted EPS of $3.02. The company saw record Q3 average daily volume of 29.4M contracts and growth in market data services revenue. CME returned nearly $1B to shareholders via dividends and share repurchases, and noted progress on cloud migration and product launches.

Original reporting
Published Oct 21, 2026, 11:23 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CME Group Reports Record Q3 Revenue of $1.74B, Adjusted Diluted EPS $3.02 — source image
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

The record revenue and cash return reinforce CME's dominant market position and may attract new institutional inflows.

02

Market read

CME's earnings beat and record trading volume provide a bullish catalyst for the stock and its sector.

03

What to watch

Potential regulatory scrutiny on crypto clearing services could temper upside.

Relevance 8/10Novelty 8/10Timing: post-market release

Background

CME Group is the world's largest derivatives exchange, reporting quarterly results that influence market participants.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group posted Q3 2026 revenue of $1.74B and adjusted EPS of $3.02, a record revenue and strong earnings beat.

Expected impact

likely upward pressure as investors price in strong revenue and cash return to shareholders

Evidence & confidence

Quarterly results exceed expectations and include a $1B share return, which typically supports the stock.

Market effects

Strong earnings may boost sentiment in the broader financial services and exchange operator sector.

U.S. markets may see a modest lift in financial stocks following CME's results.

CME's global clearing volume growth signals continued demand for derivatives across regions.

Counterpoint

If the market has already priced in the earnings beat, the stock could face short-term profit taking.

Key entities

  • CME Group

    Global derivatives exchange operator.

Related articles

$CMEHighAI 8/10

CME: 3Q 2026 Intro Script

CME Group reported record Q3 2026 earnings with $1.7B revenue (up 13% YoY) and $3.02 EPS (up 13% YoY). ADV reached 29.4M contracts (up 16% YoY), with strong growth across all asset classes. Open interest hit 128M contracts, and international volume grew 22%. The company launched new products and plans to migrate markets to Google Cloud by late 2027.

$CMEHighAI 9/10

CME: 3Q 2026 Income Statement Trend

CME Group Inc. reported financial data for Q3 2026, showing total revenues of $1,737.3 million and net income of $1,036.9 million. Operating income was $1,141.4 million with an operating margin of 66%. Basic and diluted EPS were $2.90 and $2.89 respectively.

$CMEMed

CME Group (CME) Shares Slip Despite Strong Q3 Results; Dividend

CME Group (CME) shares fell 1.2% premarket despite Q3 earnings and revenue beating estimates. Adjusted EPS was $3.02 on revenue of $1.74B, but expenses rose to $595.9M. The dividend yield is 4.04% with a high payout ratio of 95% and negative 3-year dividend growth. CME's GF Score is 88/100, indicating strong fundamentals but financial strength concerns.